Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma.

Autor: Goldlust SA; Department of Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA., Singer S; Department of Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA., Cappello LA; Department of Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA., AlMekkawi AK; Department of Neurosurgery, Saint Luke's Hospital of Kansas City, Kansas City, Missouri, USA., Lee KD; Department of Neurosurgery, Hackensack University Medical Center, Hackensack, New Jersey, USA., Ingenito AC; Department of Radiation Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA., Lewis BE; Department of Radiation Oncology, Hackensack University Medical Center, Hackensack, New Jersey, USA., Nyirenda T; Office of Research Administration, Hackensack Meridian Health, Edison, New Jersey, USA., Azmi H; Department of Neurosurgery, Hackensack University Medical Center, Hackensack, New Jersey, USA., Kaptain GJ; Department of Neurosurgery, Hackensack University Medical Center, Hackensack, New Jersey, USA.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2024 Jul 29; Vol. 6 (1), pp. vdae129. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).